We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

35 hedge funds and large institutions have $66.6M invested in InVivo Therapeutics Holdings Corp in 2015 Q2 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less call options, than puts

Call options by funds: $280K | Put options by funds: $838K

Holders
35
Holders Change
+35
Holders Change %
–
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
35
Increased
–
Reduced
–
Closed
–
Calls
$280K
Puts
$838K
Net Calls
-$558K
Net Calls Change
-$558K

Top Buyers

Rank Fund Capital Flow
1
WF
Welch & Forbes
Massachusetts
+$10.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$10M
3
BFA
BlackRock Fund Advisors
California
+$9.78M
4
BIT
BlackRock Institutional Trust
California
+$4.49M
5
State Street
State Street
Massachusetts
+$3.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$277K +$264K +1 New
NFA
27
Nationwide Fund Advisors
Ohio
$276K +$264K +1 New
AIG
28
American International Group
New York
$267K +$264K +1 New
VOYA Investment Management
29
VOYA Investment Management
Georgia
$235K +$264K +1 New
BA
30
BlackRock Advisors
Delaware
$217K +$264K +1 New
Goldman Sachs
31
Goldman Sachs
New York
$183K +$264K +1 New
Stifel Financial
32
Stifel Financial
Missouri
$178K +$264K +1 New
HKIM
33
Hayek Kallen Investment Management
Alabama
$177K +$264K +1 New
Bank of America
34
Bank of America
North Carolina
$154K +$264K +1 New
SO
35
STRS Ohio
Ohio
$137K – – –
Deutsche Bank
36
Deutsche Bank
Germany
$135K – – –
TRCT
37
Tower Research Capital (TRC)
New York
$48K – – –
LTFS
38
Ladenburg Thalmann Financial Services
Florida
$47K – – –
Simplex Trading
39
Simplex Trading
Illinois
$37K – – –
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$35K – – –
Wells Fargo
41
Wells Fargo
California
$25K – – –
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$20K – – –
BlackRock
43
BlackRock
New York
$11K – – –
Barclays
44
Barclays
United Kingdom
$8K – – –
Citigroup
45
Citigroup
New York
$6K – – –
Invesco
46
Invesco
Georgia
$5K – – –
FNBT
47
FineMark National Bank & Trust
Florida
$4K – – –
PNC Financial Services Group
48
PNC Financial Services Group
Pennsylvania
$4K – – –
PCM
49
Prelude Capital Management
New York
$3K – – –
FMB
50
Field & Main Bank
Kentucky
$2K – – –
1
2
3

NVIV Hedge Fund Activity: Q2 2015 in Review

35 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q2 2015, worth a combined $66.6M.

Buyers outnumbered sellers: 35 funds opened new NVIV positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Welch & Forbes, opening a new position worth an estimated $10.8M.

  • 35 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $66.6M of InVivo Therapeutics Holdings Corp stock for Q2 2015.
  • 35 funds opened new InVivo Therapeutics Holdings Corp positions in Q2 2015 and 0 closed out, a net change of +35 holders.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q2 2015 was Welch & Forbes, an estimated $10.8M added.

Based on aggregated 13F filings for Q2 2015.